4 Reasons Biotech Stocks Are a Buy Right Now
Biotech companies developing treatments or vaccines for the novel coronavirus have seen their stocks soar in recent weeks. Biotech stocks as a whole, however, haven't shared that good fortune. But they have fared better than the general market as the coronavirus outbreak expanded from Asia to North America, turning into a worldwide crisis. The iShares Nasdaq Biotechnology Index ETF lost 15.6%, compared to a 26.7% declinelost by the S&P 500 index so far this year.
Image Source: Getty Images
It's too early to say how long the current health and market crisis will last, but it isn't too early to start adding biotech stocks to your portfolio right now. Here's why.
Source Fool.com
